- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02908399
Thermal Images on Smartphones to Diagnose Bacterial Pneumonia in Children in Pakistan
August 28, 2017 updated by: Patricia L. Hibberd, Massachusetts General Hospital
This is a prospective study of up to 250 participants, from birth to 18 months, who have already had a chest x-ray while a patient at the National Institute of Health (NICH) in Karachi, Pakistan.
Participants will include both males and females as well as all races and ethnicities.
Participants will have thermal pictures of their chest taken by trained study staff using a Smartphone and a FLIR ONE attachment.
Thermal images will be read by trained radiologists to determine if bacterial pneumonia is present.
Results of the thermal image will then be compared to the results of the chest x-ray.
If additional images of the chest or other areas of suspected related infection are available, additional thermal images will be taken of the same location within 24 hours of the other image.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
250
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Karachi, Pakistan
- National Institute of Child Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 1 year (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 months or younger;
- patient at NICH Hospital in Karachi, Pakistan;
- had chest x-ray within last 24 hours to determine diagnosis of bacterial pneumonia;
- consent obtained from one parent
Exclusion Criteria:
- thermal image cannot be done within 24 hours of chest x-ray
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Thermal Imaging
Imaging using a thermal camera
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
diagnosis of bacterial pneumonia
Time Frame: 24 hours
|
Pneumonia is defined as the presence of an airspace opacity, lobar consolidation, or interstitial opacities on a chest x-ray.
This determination will be made by two independent radiologists blinded to each other's readings, clinical information and thermal images.
If they agree that pneumonia is either present or absent, that will be the final diagnosis.
If there is disagreement, a third independent, blinded radiologist will break the tie.
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
diagnosis of additional site of infection possibly related to bacterial pneumonia
Time Frame: up to a maximum of 28 days after original chest x-ray to diagnose pneumonia is taken
|
Thermal imaging will be used to image other potential sites of infection suspected of being related to the bacterial pneumonia if suspected by physician
|
up to a maximum of 28 days after original chest x-ray to diagnose pneumonia is taken
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Patricia L Hibberd, MD, PhD, Massachusetts General Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2016
Primary Completion (Actual)
June 1, 2017
Study Completion (Anticipated)
June 1, 2018
Study Registration Dates
First Submitted
September 8, 2016
First Submitted That Met QC Criteria
September 16, 2016
First Posted (Estimate)
September 21, 2016
Study Record Updates
Last Update Posted (Actual)
August 29, 2017
Last Update Submitted That Met QC Criteria
August 28, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016P000898
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infections - Bacterial
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
GlaxoSmithKlineTerminated
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineWithdrawn
-
Sir Run Run Shaw HospitalUniversity of BirminghamUnknown
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
GlaxoSmithKlineCompleted
Clinical Trials on FLIR ONE
-
Massachusetts General HospitalLata Medical Research Foundation, NagpurCompletedInfections - Bacterial | Pneumonia - BacterialIndia
-
Massachusetts General HospitalCompletedPneumonia, Bacterial | Infections, BacterialUnited States
-
LEO PharmaCompleted
-
NYU Langone HealthWithdrawn
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedAnesthesia, ConductionUnited States
-
Doron CarmiUnknownFever | Sore ThroatIsrael
-
Hospital for Special Surgery, New YorkCompleted
-
University Hospital of North NorwayCompleted
-
Shandong Cancer Hospital and InstituteUnknownBreast Neoplasm Female | Radiation Toxicity
-
Yonsei UniversityNot yet recruiting